Skip to main content
. 2021 Feb 25;2:647134. doi: 10.3389/falgy.2021.647134

Figure 2.

Figure 2

β-monohexosyl ceramides are increased in maternal and fetal tissues of allergic moms. Allergic moms were generated as in the timeline in Figure 1A. Tissue β-monohexosyl ceramides were measured by mass spectrometry in (A) mom plasma, (B) mom liver, (C) placenta, and (D) fetal liver on gestational day 18 of OVA-treated and saline-treated mothers. (E) Lipidomics bubble plot of fold change and significantly greater in OVA than saline treated groups for β-monohexosyl ceramides, ceramides, and sphingomylins. β-monohexosyl ceramides include both β-glucosyl and β-galactosyl ceramides. Dot size corresponds to fold change between OVA and saline group. n = 8–10 mice per group for a representative experiment of two experiments. *p < 0.05 greater in OVA than saline group, crimson red highlighted chain lengths are above the panels.